scholarly journals The molecular basis of phenylalanine hydroxylase deficiency in Croatia

2003 ◽  
Vol 21 (4) ◽  
pp. 399-399 ◽  
Author(s):  
Johannes Zschocke ◽  
Astrid Preusse ◽  
Vladimir Sarnavka ◽  
Ksenija Fumic ◽  
Du?ko Marde?ic ◽  
...  
1999 ◽  
Vol 135 (3) ◽  
pp. 375-378 ◽  
Author(s):  
Shigeo Kure ◽  
Dian-Chang Hou ◽  
Toshihiro Ohura ◽  
Hiroko Iwamoto ◽  
Shuhei Suzuki ◽  
...  

1999 ◽  
Vol 13 (6) ◽  
pp. 503-503 ◽  
Author(s):  
Bel�n P�rez ◽  
Lourdes R. Desviat ◽  
Marisel De Lucca ◽  
Veronica Cornejo ◽  
Erna Raimann ◽  
...  

1999 ◽  
Vol 68 (1) ◽  
pp. 43-47 ◽  
Author(s):  
Paule Bénit ◽  
Françoise Rey ◽  
Félicienne Blandin-Savoja ◽  
Arnold Munnich ◽  
Véronique Abadie ◽  
...  

PEDIATRICS ◽  
2003 ◽  
Vol 112 (Supplement_4) ◽  
pp. 1557-1565
Author(s):  
Heidi Erlandsen ◽  
Marianne G. Patch ◽  
Alejandra Gamez ◽  
Mary Straub ◽  
Raymond C. Stevens

Mutations in the gene encoding for phenylalanine hydroxylase (PAH) result in phenylketonuria (PKU) or hyperphenylalaninemia (HPA). Several 3-dimensional structures of truncated forms of PAH have been determined in our laboratory and by others, using x-ray crystallographic techniques. These structures have allowed for a detailed mapping of the >250 missense mutations known to cause PKU or HPA found throughout the 3 domains of PAH. This structural information has helped formulate rules that might aid in predicting the likely effects of unclassified or newly discovered PAH mutations. Also, with the aid of recent crystal structure determinations of co-factor and substrate analogs bound at the PAH active site, the recently discovered tetrahydrobiopterin-responsive PKU/HPA genotypes can be mapped onto the PAH structure, providing a molecular basis for this tetrahydrobiopterin response.


2001 ◽  
Vol 24 (3) ◽  
pp. 352-358 ◽  
Author(s):  
L. J. M. Spaapen ◽  
J. A. Bakker ◽  
C. Velter ◽  
W. Loots ◽  
M. E. Rubio-Gonzalbo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document